|
Title
|
|
|
|
Melagatran, the active form of the oral, direct thrombin inhibitor H376/95, enhances the thrombolytic effects of tissue type plasminogen activator: a possible mechanism being inhibition of thrombin-mediated proCPU activation
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Blood / American Society of Hematology. - New York, N.Y.
| |
|
Publication
|
|
|
|
New York, N.Y.
:
2000
| |
|
ISSN
|
|
|
|
0006-4971
| |
|
Volume/pages
|
|
|
|
96
:11
(2000)
, p. 52
| |
|
ISI
|
|
|
|
000165256100218
| |
|